Plakophilin-2 Truncation Variants in Patients Clinically Diagnosed With Catecholaminergic Polymorphic Ventricular Tachycardia and Decedents With Exercise-Associated Autopsy Negative Sudden Unexplained Death in the Young

Leenhardt, 1995, Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients, Circulation, 91, 1512, 10.1161/01.CIR.91.5.1512 Priori, 2002, Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia, Circulation, 106, 69, 10.1161/01.CIR.0000020013.73106.D8 Tester, 2007, A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors, Heart Rhythm, 4, 733, 10.1016/j.hrthm.2007.02.026 Liu, 2008, Catecholaminergic polymorphic ventricular tachycardia, Prog Cardiovasc Dis, 51, 23, 10.1016/j.pcad.2007.10.005 Tester, 2007, Postmortem long QT syndrome genetic testing for sudden unexplained death in the young, J Am Coll Cardiol, 49, 240, 10.1016/j.jacc.2006.10.010 Tester, 2006, The role of molecular autopsy in unexplained sudden cardiac death, Curr Opin Cardiol, 21, 166, 10.1097/01.hco.0000221576.33501.83 Laitinen, 2001, Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia, Circulation, 103, 485, 10.1161/01.CIR.103.4.485 Priori, 2001, Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia, Circulation, 103, 196, 10.1161/01.CIR.103.2.196 Ackerman, 2011, HRS/EHRA Expert Consensus Statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Heart Rhythm, 8, 1308, 10.1016/j.hrthm.2011.05.020 Lahat, 2001, Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21, Circulation, 103, 2822, 10.1161/01.CIR.103.23.2822 Postma, 2002, Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia, Circ Res, 91, E21, 10.1161/01.RES.0000038886.18992.6B Roux-Buisson, 2012, Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human, Hum Mol Genet, 21, 2759, 10.1093/hmg/dds104 Tester, 2006, Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing, Heart Rhythm, 3, 800, 10.1016/j.hrthm.2006.03.025 Corrado, 2017, Arrhythmogenic right ventricular cardiomyopathy, N Engl J Med, 376, 61, 10.1056/NEJMra1509267 Philips, 2016, 2015 update on the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy, Curr Opin Cardiol, 31, 46, 10.1097/HCO.0000000000000240 Groeneweg, 2015, Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members, Circ Cardiovasc Genet, 8, 437, 10.1161/CIRCGENETICS.114.001003 Basso, 2009, Arrhythmogenic right ventricular cardiomyopathy, Lancet, 373, 1289, 10.1016/S0140-6736(09)60256-7 Delmar, 2010, The cardiac desmosome and arrhythmogenic cardiomyopathies: from gene to disease, Circ Res, 107, 700, 10.1161/CIRCRESAHA.110.223412 Cerrone, 2017, Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm, Nat Commun, 8, 106, 10.1038/s41467-017-00127-0 Richards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, 17, 405, 10.1038/gim.2015.30 Skinner, 2011, Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds, Heart Rhythm, 8, 412, 10.1016/j.hrthm.2010.11.016 Bagnall, 2016, A prospective study of sudden cardiac death among children and young adults, N Engl J Med, 374, 2441, 10.1056/NEJMoa1510687 Lahrouchi, 2017, Utility of post-mortem genetic testing in cases of sudden arrhythmic death syndrome, J Am Coll Cardiol, 69, 2134, 10.1016/j.jacc.2017.02.046 Roux-Buisson, 2014, Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia: results of a systematic screening, Heart Rhythm, 11, 1999, 10.1016/j.hrthm.2014.07.020 Priori, 2013, HRS/EHRA/APHRS Expert Consensus Statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013, Heart Rhythm, 10, 1932, 10.1016/j.hrthm.2013.05.014 Priori, 2015, Eur Heart J, 36, 2793, 10.1093/eurheartj/ehv316 Ermakov, 2017, Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy, Heart Rhythm, 14, 564, 10.1016/j.hrthm.2016.12.010 Herman, 2012, Truncations of titin causing dilated cardiomyopathy, N Engl J Med, 366, 619, 10.1056/NEJMoa1110186